Pancreatic Cancer Research

ResearcherSeoul National UniversityActive in the last 2 years

Junyeol Kim

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0008-7262-7474; OpenAlex author ID A5007365673. Sources: OpenAlex.

Their work

Papers
1
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2024: 1 paper

Papers 1

  1. Pancreatic Cancer Treatment Targeting the HGF/c-MET Pathway: The MEK Inhibitor Trametinib. Co-author DOI 10.3390/cancers16051056↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Woo Hyun Paik · 1 shared paper, 2024 · strength 0.23
  2. In Rae Cho · 1 shared paper, 2024 · strength 0.23
  3. Sang Hyub Lee · 1 shared paper, 2024 · strength 0.23
  4. Tae Seung Lee · 1 shared paper, 2024 · strength 0.23
  5. Ji Kon Ryu · 1 shared paper, 2024 · strength 0.23
  6. Yong‐Tae Kim · 1 shared paper, 2024 · strength 0.23

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.